FindTrial
Sign In

Efficiency of bolus insulin therapy versus continuos infusion intravenous insulin in the liver transplant

Efficiency of the bolus intravenous insulin therapy versus continuos infusion intravenous therapy in patients submitted to liver transplant

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9y5tbp
Enrollment
Unknown
Registered
2016-09-29
Start date
2016-03-02
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

terminal liver disease

Interventions

Group case: Twenty-seven people during a postoperative liver transplant of 24 hours in the recovery room will have their blood glucose monitored. Each hour their blood glucose will be measured, if gre
Device
E02.319.300.508

Sponsors

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
Lead Sponsor
Hospital Universitário Walter Cantídio
Collaborator

Eligibility

Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patient in anesthesia recovery room due to liver transplant; both sex; between 18 and 70 years old; blood glucose at least 180 mg/dl

Exclusion criteria

Exclusion criteria: Patients with severe disfunction after liver transplant; blood glucose values under 150 mg/dl; death at first 48 hours; double transplant

Design outcomes

Primary

MeasureTime frame
Decrease of cases of hypoglycemia during liver transplant post operatively;Control group participants (bolus venus infusion) have showed lower percentage of hypoglycemia (25%) in liver transplant post operatively than case group (75%)—

Secondary

MeasureTime frame
Duration of the hospital stays in days;Control group participants (bolus venus insulin) had hospital stays lower (6,3 days) than case group (continuos insulin infusion pump) (13,3 days)—

Countries

Brazil

Contacts

Public ContactMárcio Araújo

Universidade da Integração Internacional da Lusofonia Afro Brasileira

marciofma@yhaoo.com.br55-85-34740905

Outcome results

None listed

Source: REBEC (via WHO ICTRP)